1 Press Release RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency TEL AVIV, ISRAEL RALEIGH, N. RedHills ADSs will continue to trade on the Nasdaq Global Market, and the Companys operations are not affected by the receipt of the Notice. , October 18, 2022, RedHill Biopharma Ltd.
🌍 RedHill Biopharma (RDHL) - Form 6-K Filing
Filing Date: 2022-10-18
Accepted: 2022-10-18 07:05:55
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: